We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$3.39B
AUM Growth
+$526M
Cap. Flow
+$586M
Cap. Flow %
17.28%
Top 10 Hldgs %
16.92%
Holding
1,543
New
205
Increased
822
Reduced
368
Closed
82
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VTA
851
DELISTED
INVESCO DYNAMIC CREDIT OPPORTUNITIES FUND
VTA
$478K 0.01%
38,738
-1,195
-3% -$15.2K
STJ
852
DELISTED
St Jude Medical
STJ
$477K 0.01%
7,935
+607
+8% +$39.7K
BHI
853
DELISTED
Baker Hughes
BHI
$476K 0.01%
7,309
+2,434
+50% +$170K
GWW icon
854
W.W. Grainger
GWW
$62.2B
$475K 0.01%
1,887
+480
+34% +$118K
LNKD
855
DELISTED
LinkedIn Corporation
LNKD
$474K 0.01%
2,283
+148
+7% +$29.6K
HSBC icon
856
HSBC
HSBC
$358B
$473K 0.01%
10,783
+883
+9% +$40.2K
PHM icon
857
Pultegroup
PHM
$24.9B
$473K 0.01%
26,773
-526
-2% -$9.91K
CAM
858
DELISTED
CAMERON INTERNATIONAL CORPORATION
CAM
$472K 0.01%
7,107
+251
+4% +$17.8K
HOG icon
859
Harley-Davidson
HOG
$2.9B
$470K 0.01%
8,080
-739
-8% -$47.3K
DNP icon
860
DNP Select Income Fund
DNP
$4.11B
$469K 0.01%
46,380
-762
-2% -$7.8K
MTUM icon
861
iShares MSCI USA Momentum Factor ETF
MTUM
$26.1B
$469K 0.01%
+7,234
New +$465K
S
862
DELISTED
Sprint Corporation
S
$469K 0.01%
+73,926
New +$503K
NMA
863
DELISTED
NUVEEN MUNI ADVANTAGE FUND
NMA
$469K 0.01%
34,803
-2,826
-8% -$38.4K
BRCM
864
DELISTED
BROADCOM CORP CL-A
BRCM
$465K 0.01%
11,513
-2,552
-18% -$99.2K
VTWO icon
865
Vanguard Russell 2000 ETF
VTWO
$17.5B
$464K 0.01%
10,542
+184
+2% +$8.45K
EWA icon
866
iShares MSCI Australia ETF
EWA
$1.45B
$463K 0.01%
19,355
+1,732
+10% +$45.6K
FAX
867
abrdn Asia-Pacific Income Fund
FAX
$600M
$462K 0.01%
13,037
-1,120
-8% -$41.1K
FFIN icon
868
First Financial Bankshares
FFIN
$5.04B
$462K 0.01%
33,266
RSPH icon
869
Invesco S&P 500 Equal Weight Health Care ETF
RSPH
$796M
$462K 0.01%
35,810
+4,300
+14% +$54.6K
FIF
870
DELISTED
FIRST TRUST ENERGY INFRASTRUCTURE FUND
FIF
$461K 0.01%
19,317
+544
+3% +$13K
IAK icon
871
iShares US Insurance ETF
IAK
$538M
$460K 0.01%
9,769
-3,646
-27% -$174K
IVZ icon
872
Invesco
IVZ
$14.3B
$459K 0.01%
11,614
+3
+0% +$118
RWJ icon
873
Invesco S&P SmallCap 600 Revenue ETF
RWJ
$2.11B
$458K 0.01%
+26,490
New +$482K
ORLY icon
874
O'Reilly Automotive
ORLY
$74.9B
$456K 0.01%
45,465
-315
-0.7% -$3.22K
WU icon
875
Western Union
WU
$2.34B
$456K 0.01%
28,418
+1,151
+4% +$19.8K

Similar funds

Cambridge Investment Research Advisors's Q3 2014 Portfolio in Review

As of Q3 2014, Cambridge Investment Research Advisors held 1,543 positions worth $3.39B, up 18% from $2.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Cambridge Investment Research Advisors deployed $586M of net new capital in Q3 2014, opening 205 new positions and adding to 822 existing holdings. Its largest new stake was Vanguard S&P 500 ETF: 556,997 shares worth $101M.

By sector, the portfolio is most concentrated in Energy at 5.4% of assets, down from 6.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was iShares Russell 3000 ETF, an estimated $20M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2014 buy was Vanguard S&P 500 ETF: 556,997 shares worth $101M.
  • Cambridge Investment Research Advisors added most to Barclays Bank Plc in Q3 2014, an estimated $45.8M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2014 reduction was iShares Russell 3000 ETF, cutting an estimated $20M.
  • Cambridge Investment Research Advisors fully exited iShares MSCI Taiwan ETF in Q3 2014, selling an estimated $1.83M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 17% of its $3.39B portfolio in Q3 2014.
  • Cambridge Investment Research Advisors opened 205 new positions and closed 82 in Q3 2014.
  • Cambridge Investment Research Advisors's portfolio value rose 18% quarter-over-quarter to $3.39B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2014, filed 5 Nov 2014.